Literature DB >> 14622957

Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry.

Yan Ji1, Marilyn E Morris.   

Abstract

Phenethyl isothiocyanate (PEITC) is a dietary compound present in cruciferous vegetables that has cancer-preventive properties. Our objective was to develop and validate a novel liquid chromatography-tandem mass spectrometry procedure to analyze PEITC concentrations in human plasma and urine. Following hexane extraction, ammonia was added to samples to derivatize PEITC to phenethylthiourea. Chromatographic separation was achieved on a C(18) column with acetonitrile/5 mM formic acid (60:40, v/v) as the mobile phase followed by tandem mass spectrometry detection in multiple reaction monitoring mode. Deuterium-labeled PEITC was used as the internal standard. The detection limit was 2 nM and calibration curves were linear from 7.8 to 2000 nM. The intra- and inter-day coefficients of variation were less than 5 and 10%, respectively. The intra- and inter-day accuracies ranged from 101.0 to 104.2% and from 102.8 to 118.6%, respectively. The recovery from spiked human plasma and urine ranged from 100.3 to 113.5% and from 98.3 to 103.9%, respectively. The assay was used to measure PEITC in plasma and urine samples obtained from subjects after consumption of 100g of watercress. This novel assay represents the first analytical method with the sensitivity and specificity to determine plasma and urine concentrations of PEITC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622957     DOI: 10.1016/j.ab.2003.08.011

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  31 in total

Review 1.  Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.

Authors:  Parul Gupta; Stephen E Wright; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.

Authors:  Dong Xiao; Shivendra Vikram Singh
Journal:  Pharm Res       Date:  2010-02-25       Impact factor: 4.200

3.  Effect of orally administered phenethyl isothiocyanate on hepatic gene expression in rats.

Authors:  Urvi Telang; Marilyn E Morris
Journal:  Mol Nutr Food Res       Date:  2010-12       Impact factor: 5.914

4.  Insights into the mode of action of benzyl isothiocyanate on Campylobacter jejuni.

Authors:  Virginie Dufour; Martin Stahl; Eric Rosenfeld; Alain Stintzi; Christine Baysse
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

5.  Pharmacokinetics of dietary phenethyl isothiocyanate in rats.

Authors:  Yan Ji; Yuhsin Kuo; Marilyn E Morris
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

6.  Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells.

Authors:  Urvi Telang; Daniel A Brazeau; Marilyn E Morris
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

7.  Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36.

Authors:  Lianguo Kang; Zhao-Yi Wang
Journal:  J Cell Mol Med       Date:  2009-10-15       Impact factor: 5.310

8.  ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.

Authors:  Urvi Telang; Yan Ji; Marilyn E Morris
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

9.  Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells.

Authors:  Dong Xiao; Anna A Powolny; Shivendra V Singh
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

10.  Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model.

Authors:  Silvia D Stan; Shivendra V Singh; David C Whitcomb; Randall E Brand
Journal:  Nutr Cancer       Date:  2013-11-06       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.